Chen et al. developed an albumin-based injectable hydrogel, and in vitro and in vivo results showed that the albumin-based hydrogel exhibited significant antitumor efficacy in reducing tumor size (The tumor volume after treatment with this DOX-loading hydrogel was only about 1/6 of the tumor volume in control group). This evidence concerns the gene ALB and neoplasm.